Literature DB >> 34711458

Central Nervous System Metastases.

Edwin Nieblas-Bedolla1, Jeffrey Zuccato2, Harriet Kluger3, Gelareh Zadeh4, Priscilla K Brastianos5.   

Abstract

The proportion of patients developing central nervous system (CNS) metastasis is increasing. Most are identified once symptomatic. Surgical resection is indicated for solitary or symptomatic brain metastases, separation surgery for compressive radioresistant spinal metastases, and instrumentation for unstable spinal lesions. Surgical biopsies are performed when histological diagnoses are required. Stereotactic radiosurgery is an option for limited small brain metastases and radioresistant spinal metastases. Whole-brain radiotherapy is reserved for extensive brain metastases and leptomeningeal disease with approaches to reduce cognitive side effects. Radiosensitive and inoperable spinal metastases typically receive external beam radiotherapy. Systemic therapy is increasingly being utilized for CNS metastases.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Brain metastases; Central nervous system; Spinal metastases; Systemic cancer

Mesh:

Year:  2021        PMID: 34711458     DOI: 10.1016/j.hoc.2021.08.004

Source DB:  PubMed          Journal:  Hematol Oncol Clin North Am        ISSN: 0889-8588            Impact factor:   3.722


  2 in total

Review 1.  Non-coding RNAs in the regulation of blood-brain barrier functions in central nervous system disorders.

Authors:  Ping Sun; Milton H Hamblin; Ke-Jie Yin
Journal:  Fluids Barriers CNS       Date:  2022-03-26

2.  30-day mortality in patients treated for brain metastases: extracranial causes dominate.

Authors:  Carsten Nieder; Luka Stanisavljevic; Siv Gyda Aanes; Bård Mannsåker; Ellinor Christin Haukland
Journal:  Radiat Oncol       Date:  2022-05-12       Impact factor: 3.481

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.